Effect of Interleukin-2 on HIV Treatment Interruption
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
Interleukin-2 (IL-2) helps the body make infection-fighting white blood cells, including CD4
and CD8 T cells. One HIV treatment strategy is planned treatment interruption (stopping
anti-HIV drugs when CD4 count and level of virus in the blood are at certain levels). The
purpose of this study is to see if IL-2 used with potent anti-HIV drugs allows for longer HIV
treatment interruptions.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)